Skip Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 15, Issue 18

2023 September-2 - 249 articles

Cover Story: Primary tumor invasiveness and metastasis formation at distant sites strongly impact the prognosis and quality of life of cancer patients. A better understanding of these mechanisms and the development of new therapies are urgently needed. Extracellular vesicles (EVs) are lipid-enveloped particles involved in inter-tissue and inter-cell communication. This review article focuses on the impact of EVs released by tumor cells, specifically on cancer cell migration and metastasis and on the development of EV-based therapeutic approaches. Moreover, we propose EV sorting as a route alternative to secretion or cell membrane binding, influencing downstream signaling and the final effect on target cells, with strong implications for tumorigenesis. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (249)

  • Review
  • Open Access
7 Citations
3,819 Views
23 Pages

21 September 2023

The MET proto-oncogene encodes a pivotal tyrosine kinase receptor, binding the hepatocyte growth factor (HGF, also known as scatter factor, SF) and governing essential biological processes such as organogenesis, tissue repair, and angiogenesis. The p...

  • Article
  • Open Access
14 Citations
4,241 Views
14 Pages

Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience

  • Aaron Trando,
  • Anna Ter-Zakarian,
  • Phillip Yeung,
  • Aaron M. Goodman,
  • Ayad Hamdan,
  • Michael Hurley,
  • Ah-Reum Jeong and
  • Dimitrios Tzachanis

21 September 2023

Chimeric antigen receptor T-cell (CAR T-cell) therapy has revolutionized the treatment of relapsed/refractory (R/R) large B-cell lymphoma (LBCL). We describe the real-world baseline characteristics, efficacy, safety, and post-relapse outcomes of adul...

  • Article
  • Open Access
3 Citations
3,589 Views
14 Pages

Predicting Risk of Severe Toxicity and Early Death in Older Adult Patients Treated with Chemotherapy

  • Jaime Feliu,
  • Ana Belén Custodio,
  • Alvaro Pinto-Marín,
  • Oliver Higuera,
  • Miriam Pérez-González,
  • Laura del Pino,
  • Leticia Ruiz-Jiménez,
  • Darío Sánchez-Cabero,
  • Isabel Viera and
  • Enrique Espinosa
  • + 1 author

21 September 2023

Background: Determining the risk of grade 3–5 toxicity and early death (ED) is important to plan chemotherapy in older adult patients with cancer. Our objective was to identify factors predicting these complications at the time of treatment ini...

  • Review
  • Open Access
5 Citations
2,804 Views
20 Pages

Trial Design for Cancer Immunotherapy: A Methodological Toolkit

  • Everardo D. Saad,
  • Elisabeth Coart,
  • Vaiva Deltuvaite-Thomas,
  • Leandro Garcia-Barrado,
  • Tomasz Burzykowski and
  • Marc Buyse

21 September 2023

Immunotherapy with checkpoint inhibitors (CPIs) and cell-based products has revolutionized the treatment of various solid tumors and hematologic malignancies. These agents have shown unprecedented response rates and long-term benefits in various sett...

  • Article
  • Open Access
3 Citations
3,246 Views
13 Pages

Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial

  • Lisa B. Leypoldt,
  • Maria Gavriatopoulou,
  • Britta Besemer,
  • Hans Salwender,
  • Marc S. Raab,
  • Axel Nogai,
  • Cyrus Khandanpour,
  • Volker Runde,
  • Anna Jauch and
  • Katja C. Weisel
  • + 5 authors

21 September 2023

Renal function impairment (RI) is a common complication in multiple myeloma (MM). However, limited data exist on the safety and efficacy of anti-MM regimens in patients with severe RI, as these patients are frequently excluded from clinical trials. T...

  • Article
  • Open Access
4 Citations
3,175 Views
22 Pages

21 September 2023

The present study was aimed at identifying novel proteins in endometrial cancer (EC), employing proteomic analysis of tissues obtained after surgery. A differential MS-based proteomic analysis was conducted from whole tissues dissected from biopsies...

  • Review
  • Open Access
12 Citations
4,961 Views
24 Pages

Can Exercise Enhance the Efficacy of Checkpoint Inhibition by Modulating Anti-Tumor Immunity?

  • Christina Brummer,
  • Tobias Pukrop,
  • Joachim Wiskemann,
  • Christina Bruss,
  • Ines Ugele and
  • Kathrin Renner

21 September 2023

Immune checkpoint inhibition (ICI) has revolutionized cancer therapy. However, response to ICI is often limited to selected subsets of patients or not durable. Tumors that are non-responsive to checkpoint inhibition are characterized by low anti-tumo...

  • Review
  • Open Access
7 Citations
4,714 Views
32 Pages

Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas

  • Gildas Gabiache,
  • Charline Zadro,
  • Laura Rozenblum,
  • Delphine Vezzosi,
  • Céline Mouly,
  • Matthieu Thoulouzan,
  • Rosine Guimbaud,
  • Philippe Otal,
  • Lawrence Dierickx and
  • Fatima-Zohra Mokrane
  • + 3 authors

21 September 2023

In this comprehensive review, we aimed to discuss the current state-of-the-art medical imaging for pheochromocytomas and paragangliomas (PPGLs) diagnosis and treatment. Despite major medical improvements, PPGLs, as with other neuroendocrine tumors (N...

  • Article
  • Open Access
2 Citations
2,200 Views
10 Pages

Proximal Tibia Tumour Location and Curettage Are Major Risk Factors of Local Recurrence in Giant Cell Tumour of Bone

  • Michal Mahdal,
  • Tomáš Tomáš,
  • Vasileios Apostolopoulos,
  • Dagmar Adámková,
  • Peter Múdry,
  • Iva Staniczková Zambo and
  • Lukáš Pazourek

21 September 2023

Giant cell tumour of bone (GCTB) is one of the most common local aggressive tumourous lesions with a wide variety of biological behaviour. However, there are no clear indicative criteria when choosing the type of procedure and the complication rates...

  • Article
  • Open Access
1 Citations
2,288 Views
11 Pages

Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies

  • Youngtaek Kim,
  • Joon Yeon Hwang,
  • Dong Kwon Kim,
  • Kwangmin Na,
  • Seul Lee,
  • Sujeong Baek,
  • Seong-san Kang,
  • Seung Min Yang,
  • Mi Hyun Kim and
  • Kyoung-Ho Pyo
  • + 8 authors

21 September 2023

(1) Background: This study investigated whether polo-like kinase 4 (PLK4) is a suitable therapeutic target or biomarker for lung adenocarcinoma (LUAD). (2) Methods: We acquired LUAD data from The Cancer Genome Atlas (TCGA) database through the UCSC X...

  • Article
  • Open Access
5 Citations
1,977 Views
16 Pages

21 September 2023

Background: The complement component C5a receptor 1 (C5aR1) regulates cancer immunity. This retrospective study aimed to assess its prognostic value in high-grade glioma (HGG) and predict C5aR1 expression using a radiomics approach. Methods: Among 29...

  • Article
  • Open Access
6 Citations
2,587 Views
16 Pages

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients

  • Torgeir Mo,
  • Siri Helene Bertelsen Brandal,
  • Oliver Marcel Geier,
  • Olav Engebråten,
  • Line Brennhaug Nilsen,
  • Vessela N. Kristensen,
  • Knut Håkon Hole,
  • Tord Hompland,
  • Thomas Fleischer and
  • Therese Seierstad

21 September 2023

Anti-VEGF (vascular endothelial growth factor) treatment improves response rates, but not progression-free or overall survival in advanced breast cancer. It has been suggested that subgroups of patients may benefit from this treatment; however, the e...

  • Article
  • Open Access
7 Citations
2,174 Views
14 Pages

The Association between Lymph Node Dissection and Survival in Lymph Node-Negative Upper Urinary Tract Urothelial Cancer

  • Aleksander Ślusarczyk,
  • Piotr Zapała,
  • Tomasz Piecha,
  • Paweł Rajwa,
  • Marco Moschini and
  • Piotr Radziszewski

21 September 2023

The benefit of lymph node dissection (LND) during radical nephroureterectomy (RNU) in lymph node (LN)-negative (cN0/pN0) UTUC remains controversial. We aimed to assess the association between LND and its extent and survival in LN-negative UTUC. The S...

  • Correction
  • Open Access
1,457 Views
3 Pages

21 September 2023

The authors wish to revise two words in Table 1 row 3, and the first paragraph of Section 2 [...]

  • Review
  • Open Access
11 Citations
4,435 Views
14 Pages

MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation

  • Cecil M. Benitez,
  • Michael L. Steinberg,
  • Minsong Cao,
  • X. Sharon Qi,
  • James M. Lamb,
  • Amar U. Kishan and
  • Luca F. Valle

21 September 2023

Technological advances in MRI-guided radiation therapy (MRIgRT) have improved real-time visualization of the prostate and its surrounding structures over CT-guided radiation therapy. Seminal studies have demonstrated safe dose escalation achieved thr...

  • Article
  • Open Access
5 Citations
4,562 Views
12 Pages

Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer

  • Laura Valerio,
  • Cristina Dalmiglio,
  • Fabio Maino,
  • Elisa Mattii,
  • Andrea Trimarchi,
  • Alessandra Cartocci and
  • Maria Grazia Castagna

21 September 2023

Background: In recent years, there has been a renewed interest in thyroid cancer management paradigms that use individualized risk assessments as the basis for treatment and follow-up recommendations. In this study, we assumed that the long-term foll...

  • Article
  • Open Access
15 Citations
2,688 Views
17 Pages

21 September 2023

Lung cancer is typically classified into small-cell carcinoma and non-small-cell carcinoma. Non-small-cell carcinoma accounts for approximately 85% of all lung cancers. Low-dose chest computed tomography (CT) can quickly and non-invasively diagnose l...

  • Review
  • Open Access
7 Citations
4,531 Views
17 Pages

21 September 2023

Myelofibrosis (MF) is a clonal myeloproliferative neoplasm (MPN) characterized clinically by cytopenias, fatigue, and splenomegaly stemming from extramedullary hematopoiesis. MF commonly arises from mutations in JAK2, MPL, and CALR, which manifests a...

  • Review
  • Open Access
20 Citations
7,102 Views
26 Pages

Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function

  • Silvia Belluti,
  • Carol Imbriano and
  • Livio Casarini

20 September 2023

Estrogens are almost ubiquitous steroid hormones that are essential for development, metabolism, and reproduction. They exert both genomic and non-genomic action through two nuclear receptors (ERα and ERβ), which are transcription factors...

  • Article
  • Open Access
3,031 Views
16 Pages

Using Single-Case Experimental Design and Patient-Reported Outcome Measures to Evaluate the Treatment of Cancer-Related Cognitive Impairment in Clinical Practice

  • Robert J. Ferguson,
  • Lauren Terhorst,
  • Benjamin Gibbons,
  • Donna M. Posluszny,
  • Hsuan Chang,
  • Dana H. Bovbjerg and
  • Brenna C. McDonald

20 September 2023

Cancer-related cognitive impairment (CRCI) affects a large proportion of cancer survivors and has significant negative effects on survivor function and quality of life (QOL). Treatments for CRCI are being developed and evaluated. Memory and attention...

  • Article
  • Open Access
2 Citations
1,919 Views
16 Pages

Radiomic Assessment of Radiation-Induced Alterations of Skeletal Muscle Composition in Head and Neck Squamous Cell Carcinoma within the Currently Clinically Defined Optimal Time Window for Salvage Surgery—A Pilot Study

  • Matthias Santer,
  • Herbert Riechelmann,
  • Benedikt Hofauer,
  • Joachim Schmutzhard,
  • Wolfgang Freysinger,
  • Annette Runge,
  • Timo Maria Gottfried,
  • Philipp Zelger,
  • Gerlig Widmann and
  • Daniel Dejaco
  • + 4 authors

20 September 2023

Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) frequently require primary radiochemotherapy (RCT). Despite intensity modulation, the desired radiation-induced effects observed in HNSCC may also be observed as side effect...

  • Article
  • Open Access
2 Citations
2,028 Views
13 Pages

Clinical Outcomes in AYAs (Adolescents and Young Adults) Treated with Proton Therapy for Uveal Melanoma: A Comparative Matching Study with Elder Adults

  • Alessia Pica,
  • Damien C. Weber,
  • Claude Schweizer,
  • Aziz Chaouch,
  • Leonidas Zografos and
  • Ann Schalenbourg

20 September 2023

Objective: The aim of this study was to compare the clinical outcomes of adolescents and young adults (AYAs) with those of elder adult patients treated with proton therapy (PT) for uveal melanoma (UM). Material and Methods: A retrospective, comparati...

  • Review
  • Open Access
5 Citations
4,353 Views
21 Pages

Is Insulin Receptor Substrate4 (IRS4) a Platform Involved in the Activation of Several Oncogenes?

  • Luis G. Guijarro,
  • Francisco Javier Justo Bermejo,
  • Diego Liviu Boaru,
  • Patricia De Castro-Martinez,
  • Diego De Leon-Oliva,
  • Oscar Fraile-Martínez,
  • Cielo Garcia-Montero,
  • Melchor Alvarez-Mon,
  • María del Val Toledo-Lobo and
  • Miguel A. Ortega

20 September 2023

The IRS (insulin receptor substrate) family of scaffold proteins includes insulin receptor substrate-4 (IRS4), which is expressed only in a few cell lines, including human kidney, brain, liver, and thymus and some cell lines. Its N-terminus carries a...

  • Article
  • Open Access
5 Citations
2,607 Views
19 Pages

20 September 2023

Predictive models play a crucial role in RBMs to analyze performance indicator results to manage unexpected events and make timely decisions to resolve them. Their use in Mexico is deficient, and monitoring and evaluation are among the weakest pillar...

  • Review
  • Open Access
34 Citations
4,910 Views
16 Pages

Angiogenesis in Lung Cancer: Understanding the Roles of Growth Factors

  • Tchawe Yvan Sinclair Ngaha,
  • Angelina V. Zhilenkova,
  • Freddy Elad Essogmo,
  • Ikenna K. Uchendu,
  • Moses Owoicho Abah,
  • Lionel Tabola Fossa,
  • Zaiana D. Sangadzhieva,
  • Varvara D. Sanikovich,
  • Alexander S. Rusanov and
  • Marina I. Sekacheva
  • + 5 authors

20 September 2023

Research has shown the role of growth factors in lung cancer angiogenesis. Angiogenesis promotes lung cancer progression by stimulating tumor growth, enhancing tumor invasion, contributing to metastasis, and modifying immune system responses within t...

  • Article
  • Open Access
9 Citations
3,935 Views
16 Pages

Inhibition of EphA3 Expression in Tumour Stromal Cells Suppresses Tumour Growth and Progression

  • Mary E. Vail,
  • Rae H. Farnsworth,
  • Linda Hii,
  • Stacey Allen,
  • Sakshi Arora,
  • Robin L. Anderson,
  • Ross A. Dickins,
  • Akira Orimo,
  • Sunny Z. Wu and
  • Peter W. Janes
  • + 2 authors

20 September 2023

Tumour progression relies on interactions with untransformed cells in the tumour microenvironment (TME), including cancer-associated fibroblasts (CAFs), which promote blood supply, tumour progression, and immune evasion. Eph receptor tyrosine kinases...

  • Article
  • Open Access
8 Citations
2,505 Views
17 Pages

Simultaneous Integrated Boost for Dose Escalation in Node-Positive Cervical Cancer: 5-Year Experience in a Single Institution

  • Elki Sze-Nga Cheung,
  • Frederick Chun-Him Law,
  • Nelson Tsz-Cheong Fung,
  • Inda Sung Soong,
  • Rico Hing-Ming Hung,
  • Teddy Ka-Ho Tse,
  • Ken Ka-Shing Wong and
  • Philip Yuguang Wu

20 September 2023

This study retrospectively evaluates clinical outcomes of dose escalation to involved nodes using volumetric modulated arc therapy (VMAT) with simultaneous integrated boost (SIB) for node-positive locally advanced cervical cancer (LACC) at a single i...

  • Editorial
  • Open Access
1 Citations
1,284 Views
4 Pages

20 September 2023

We extend our appreciation to the authors who have made substantial contributions to the Special Issue focusing on “Colorectal Cancer Metastasis” [...]

  • Review
  • Open Access
8 Citations
4,326 Views
28 Pages

Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells

  • Farjana Afrin,
  • Sameena Mateen,
  • Jordan Oman,
  • James C. K. Lai,
  • Jared J. Barrott and
  • Srinath Pashikanti

20 September 2023

Molecular targeting strategies have been used for years in order to control cancer progression and are often based on targeting various enzymes involved in metabolic pathways. Keeping this in mind, it is essential to determine the role of each enzyme...

  • Article
  • Open Access
3 Citations
2,003 Views
13 Pages

Impact of Sepsis on the Oncologic Outcomes of Advanced Epithelial Ovarian Cancer Patients: A Multicenter Observational Study

  • Sherin A. Said,
  • Joanne A. de Hullu,
  • Maaike A. van der Aa,
  • Janneke E. W. Walraven,
  • Ruud L. M. Bekkers,
  • Brigitte F. M. Slangen,
  • Peter Pickkers and
  • Anne M. van Altena

20 September 2023

Objective: The sepsis-induced inflammatory response may potentially affect malignant cells. Recently, a case of spontaneous regression of a histologically confirmed International Federation of Gynecology and Obstetrics (FIGO) stage IIIC epithelial ov...

  • Review
  • Open Access
5 Citations
4,480 Views
14 Pages

Vital Signs in Palliative Care: A Scoping Review

  • Jenny Power,
  • Craig Gouldthorpe and
  • Andrew Davies

20 September 2023

Vital signs are routinely measured in secondary healthcare settings and can be used to detect clinical problems, guide treatment, and monitor response to treatment. Vital signs are less frequently measured in palliative care settings. Reasons for thi...

  • Review
  • Open Access
3 Citations
2,799 Views
20 Pages

20 September 2023

Cancer-associated thrombosis (CAT) is a leading cause of death among patients with cancer. CAT can manifest itself as venous thromboembolism (VTE), in the form of deep vein thrombosis or pulmonary embolism, or arterial thromboembolism. The pathophysi...

  • Article
  • Open Access
4 Citations
3,192 Views
23 Pages

Association between AHR Expression and Immune Dysregulation in Pancreatic Ductal Adenocarcinoma: Insights from Comprehensive Immune Profiling of Peripheral Blood Mononuclear Cells

  • Arenida Bartkeviciene,
  • Aldona Jasukaitiene,
  • Inga Zievyte,
  • Darius Stukas,
  • Sandra Ivanauskiene,
  • Daiva Urboniene,
  • Toivo Maimets,
  • Kristaps Jaudzems,
  • Astra Vitkauskiene and
  • Antanas Gulbinas
  • + 2 authors

19 September 2023

Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), has an immune suppressive environment that allows tumour cells to evade the immune system. The aryl-hydrocarbon receptor (AHR) is a transcription factor that can be activated by...

  • Article
  • Open Access
8 Citations
6,157 Views
12 Pages

A Comparison of the Prognostic Effects of Fine Needle Aspiration and Core Needle Biopsy in Patients with Breast Cancer: A Nationwide Multicenter Prospective Registry

  • Hongki Gwak,
  • Sang Seok Woo,
  • Se Jeong Oh,
  • Jee Ye Kim,
  • Hee-Chul Shin,
  • Hyun Jo Youn,
  • Jung Whan Chun,
  • Dasom Lee and
  • Seong Hwan Kim

19 September 2023

(1) Background: Breast core needle biopsy (CNB) is preferred over fine needle aspiration (FNA) as it has higher sensitivity and specificity and enables immunohistochemical evaluation. However, breast FNA remains widely used because of its low cost, m...

  • Article
  • Open Access
7 Citations
2,491 Views
13 Pages

19 September 2023

In recent years, there has been a notable rise in the incidence of breast cancer among young patients, who exhibit worse survival outcomes and distinct characteristics compared to intermediate and elderly patients. Therefore, it is imperative to iden...

  • Article
  • Open Access
10 Citations
3,104 Views
25 Pages

Prediction of Rapid Early Progression and Survival Risk with Pre-Radiation MRI in WHO Grade 4 Glioma Patients

  • Walia Farzana,
  • Mustafa M. Basree,
  • Norou Diawara,
  • Zeina A. Shboul,
  • Sagel Dubey,
  • Marie M. Lockhart,
  • Mohamed Hamza,
  • Joshua D. Palmer and
  • Khan M. Iftekharuddin

19 September 2023

Recent clinical research describes a subset of glioblastoma patients that exhibit REP prior to the start of radiation therapy. Current literature has thus far described this population using clinicopathologic features. To our knowledge, this study is...

  • Article
  • Open Access
13 Citations
4,337 Views
24 Pages

A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages

  • Iseulys Richert,
  • Paul Berchard,
  • Lhorra Abbes,
  • Alexey Novikov,
  • Kamel Chettab,
  • Alexandra Vandermoeten,
  • Charles Dumontet,
  • Marie Karanian,
  • Jerome Kerzerho and
  • Aurélie Dutour
  • + 2 authors

19 September 2023

Osteosarcoma (OsA) has limited treatment options and stagnant 5-year survival rates. Its immune microenvironment is characterized by a predominance of tumor-associated macrophages (TAMs), whose role in OsA progression remain unclear. Nevertheless, im...

  • Systematic Review
  • Open Access
8 Citations
4,339 Views
25 Pages

Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis

  • Racheal Louise Johnson,
  • Subhasheenee Ganesan,
  • Amudha Thangavelu,
  • Georgios Theophilou,
  • Diederick de Jong,
  • Richard Hutson,
  • David Nugent,
  • Timothy Broadhead,
  • Alexandros Laios and
  • Nicolas Michel Orsi
  • + 1 author

19 September 2023

Results of recent clinical trials using the immune check point inhibitors (ICI) pembrolizumab or dostarlimab with/without lenvatinib has led to their approval for specific molecular subgroups of advanced recurrent endometrial cancer (EC). Herein, we...

  • Article
  • Open Access
3 Citations
2,457 Views
9 Pages

Insights into Melanoma Clinical Practice: A Perspective for Future Research

  • Giang T. Lam,
  • Carmela Martini,
  • Tiffany Brooks,
  • Sarita Prabhakaran,
  • Ashley M. Hopkins,
  • Ben S.-Y. Ung,
  • Jingying Tang,
  • Maria C. Caruso,
  • Robert D. Brooks and
  • Jessica M. Logan
  • + 7 authors

19 September 2023

Background: Early diagnosis is the key to improving outcomes for patients with melanoma, and this requires a standardized histological assessment approach. The objective of this survey was to understand the challenges faced by clinicians when assessi...

  • Article
  • Open Access
6 Citations
2,700 Views
13 Pages

Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study

  • Frederik A. Stuebs,
  • Anna K. Dietl,
  • Martin C. Koch,
  • Werner Adler,
  • Carol Immanuel Geppert,
  • Arndt Hartmann,
  • Antje Knöll,
  • Grit Mehlhorn,
  • Matthias W. Beckmann and
  • Paul Gass
  • + 5 authors

19 September 2023

(1) Background: Vaginal intraepithelial neoplasia (VaIN) is a rare premalignant disease caused by persistent human papillomavirus (HPV) infection. Diagnosing VaIN is challenging; abnormal cytology and positive HPV tests are usually the first signs, b...

  • Article
  • Open Access
18 Citations
3,339 Views
13 Pages

Social Determinants of Health Data Improve the Prediction of Cardiac Outcomes in Females with Breast Cancer

  • Nickolas Stabellini,
  • Jennifer Cullen,
  • Justin X. Moore,
  • Susan Dent,
  • Arnethea L. Sutton,
  • John Shanahan,
  • Alberto J. Montero and
  • Avirup Guha

19 September 2023

Cardiovascular disease is the leading cause of mortality among breast cancer (BC) patients aged 50 and above. Machine Learning (ML) models are increasingly utilized as prediction tools, and recent evidence suggests that incorporating social determina...

  • Review
  • Open Access
19 Citations
5,037 Views
25 Pages

Changes in the Acetylcholinesterase Enzymatic Activity in Tumor Development and Progression

  • Benjamín Pérez-Aguilar,
  • Jens U. Marquardt,
  • Encarnación Muñoz-Delgado,
  • Rosa María López-Durán,
  • María Concepción Gutiérrez-Ruiz,
  • Luis E. Gomez-Quiroz and
  • José Luis Gómez-Olivares

19 September 2023

Acetylcholinesterase is a well-known protein because of the relevance of its enzymatic activity in the hydrolysis of acetylcholine in nerve transmission. In addition to the catalytic action, it exerts non-catalytic functions; one is associated with a...

  • Article
  • Open Access
12 Citations
2,922 Views
19 Pages

19 September 2023

Glioma grading plays a pivotal role in guiding treatment decisions, predicting patient outcomes, facilitating clinical trial participation and research, and tailoring treatment strategies. Current glioma grading in the clinic is based on tissue acqui...

  • Systematic Review
  • Open Access
10 Citations
2,646 Views
17 Pages

Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes

  • Raffaello Roesel,
  • Letizia Deantonio,
  • Lorenzo Bernardi,
  • Maria Luisa Garo,
  • Pietro Majno-Hurst,
  • Alberto Vannelli,
  • Marco Cefalì,
  • Maria Celeste Palmarocchi,
  • Maria Carla Valli and
  • Sara De Dosso
  • + 2 authors

19 September 2023

Background: Despite advances in treatment, the prognosis of resectable pancreatic adenocarcinoma remains poor. Neoadjuvant therapy (NAT) has gained great interest in hopes of improving survival. However, the results of available studies based on diff...

  • Article
  • Open Access
10 Citations
2,207 Views
16 Pages

19 September 2023

Immunogenic lipid-coated mesoporous silica nanoparticles (ILM) present pathogen-associated molecular patterns (PAMPs) on the nanoparticle surface to engage pathogen-associated receptors on immune cells. The mesoporous core is capable of loading addit...

  • Article
  • Open Access
6 Citations
3,655 Views
11 Pages

Reducing Chemotherapy Waiting Times in the Ambulatory Setting of a Tertiary Cancer Centre Using a Design Thinking Approach

  • Wei-Ying Jen,
  • Zhi Yao Chan,
  • Yee Mei Lee,
  • Noel Ng,
  • Belinda Tan,
  • Constance Teo,
  • Yuet Peng Wong,
  • Cheng Ean Chee and
  • Yen-Lin Chee

19 September 2023

Introduction: Chemotherapy is complex. We hypothesized that a design thinking approach could redesign preparatory processes and reduce wait times. Methods: A multidisciplinary process mapping exercise was undertaken to understand the current processe...

  • Article
  • Open Access
1 Citations
2,414 Views
18 Pages

Single-Step IGHV Next-Generation Sequencing Detects Clonality and Somatic Hypermutation in Lymphoid Malignancies: A Phase III Diagnostic Accuracy Study

  • Anna Gazzola,
  • Mohsen Navari,
  • Claudia Mannu,
  • Riccardo Donelli,
  • Maryam Etebari and
  • Pier Paolo Piccaluga

19 September 2023

Background: Multiplex PCR based on consensus primers followed by capillary electrophoresis and Sanger sequencing are considered as the gold standard method for the evaluation of clonality and somatic hypermutation in lymphoid malignancies. As an alte...

  • Article
  • Open Access
12 Citations
4,470 Views
13 Pages

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study

  • Nicola Stefano Fracchiolla,
  • Mariarita Sciumè,
  • Cristina Papayannidis,
  • Antonella Vitale,
  • Sabina Chiaretti,
  • Mario Annunziata,
  • Fabio Giglio,
  • Prassede Salutari,
  • Fabio Forghieri and
  • Antonio Curti
  • + 21 authors

19 September 2023

Background: Blinatumomab (Blina) and inotuzumab ozogamicin (InO) has improved the outcome of relapsed/refractory B-lymphoblastic leukemia (R/R B-ALL). However, little is known about the outcome after recurrence and re-treatment with immunotherapy. Me...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694